Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 986,851 | reported | 04 May 2026 | tx 15+1,718,005−233,154 |
| Fulcrum Therapeutics, Inc. | 160,000 | reported | 09 Feb 2023 | tx 2+360,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | SALE | Spero Therapeutics, Inc. | 25,240 | 2.51 USD | |
| 06 Feb 2026 | SALE | Spero Therapeutics, Inc. | 37,101 | 2.36 USD | |
| 06 Feb 2026 | SALE | Spero Therapeutics, Inc. | 50,816 | 2.36 USD | |
| 02 Feb 2026 | SALE | Spero Therapeutics, Inc. | 18,442 | 2.20 USD | |
| 02 Feb 2026 | GRANT_AWARD | Spero Therapeutics, Inc. | 249,000 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | Spero Therapeutics, Inc. | 498,000 | 0.00 USD | deriv |
| 07 Nov 2025 | SALE | Spero Therapeutics, Inc. | 40,270 | 2.37 USD | |
| 02 May 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 185,000 | 0.00 USD | |
| 05 Feb 2025 | SALE | Spero Therapeutics, Inc. | 20,689 | 0.78 USD | |
| 03 Feb 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 100,000 | 0.00 USD | |
| 03 Feb 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 266,139 | 0.00 USD | |
| 08 Nov 2024 | SALE | Spero Therapeutics, Inc. | 17,245 | 1.30 USD | |
| 07 Nov 2024 | SALE | Spero Therapeutics, Inc. | 23,351 | 1.31 USD | |
| 01 Feb 2024 | GRANT_AWARD | Spero Therapeutics, Inc. | 119,866 | 0.00 USD | |
| 13 Nov 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 300,000 | 0.00 USD | |
| 09 Feb 2023 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Fulcrum Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |